68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT

Increased Circulatory Level of Biologically Active Full-Length FGF-23 in Patients with Hypophosphatemic Rickets/Osteomalacia

Y. Yamazaki, Ryo Okazaki, Minako Shibata et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 675 citations

Medicine, Endocrinology, Pathobiology +14

Bone mineralization defects and vitamin D deficiency: Histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients

Matthias Priemel, Christoph von Domarus, Till Orla Klatte et al. · Journal of Bone and Mineral Research · 2009 · 649 citations

Medicine, Endocrinology, Bone Metabolism +16

Most Osteomalacia-associated Mesenchymal Tumors Are a Single Histopathologic Entity

Andrew L. Folpe, Julie C. Fanburg–Smith, Steven D. Billings et al. · The American Journal of Surgical Pathology · 2004 · 647 citations

Medicine, Nephrology, Pathology +14

Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?

Pedro Antunes, Mihaela Ginj, Hanwen Zhang et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2007 · 392 citations · Full text

Medicine, Oncology, Radiology +13

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

Damian Wild, Jörg Schmitt, Mihaela Ginj et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 301 citations

Medicine, Endocrinology, Pharmacology +8